Article

Drug Makers Shifting Towards Targeted Cancer Drugs

The continuing shift away from one-size-fits-all cancer treatments will be on display this week when a medical society releases clinical data for drugs that target unique molecular features of cancer cells.

PFE

+1.61%

JNJ

+0.31%

Pfizer Inc. , GlaxoSmithKline PLC (GSK, GSK.LN) and Johnson & Johnson are among those whose drugs will be highlighted when the American Society of Clinical Oncology on Wednesday releases summaries of more than 4,500 cancer studies, two weeks ahead of ASCO's annual scientific meeting.

Read the full story: http://hcp.lv/L7lWOL

Source: Market Watch (The Wall Street Journal)

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Carrie Kitko
Dr Ibrahim Aldoss
1 expert is featured in this series.
Miriam Freimer, MD
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Dr John Mascarenhas
5 experts are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo